 |
Renowned cancer researcher, Dr. Lisanti is currently Professor of
Cancer Biology at Jefferson Medical College of Thomas Jefferson
University and Jefferson’s Kimmel Cancer Center in Philadelphia. He
also holds the Margaret Q. Landenberger Endowed Professorship for
Breast Cancer Research at Jefferson. His extensive contributions to
scientific research have earned him a regular place on the list of
Most-Cited Scientists in Biology and Biochemistry (Source: Thomson’s
Essential Science Indicators; 2007 ranking: #23). To date he has
published approximately 270 scientific papers, many which appear in
what Dr. Lisanti calls “my favorite journal,”
The
American Journal of Pathology.
The AJP has over 100 years of
publication history, and is widely recognized as the premiere
journal in disease pathobiology, garnering over 30,000 citations to
its articles each year and earning its place as the #1 ranked
journal in field of pathology (Source: Thomson’s Journal Citation
Reports). The breadth and depth of Dr. Lisanti’s interest in
disease investigation matches the broad and far-reaching scope of
the AJP, characterized by the journal’s tagline, “The
Cellular and Molecular Biology of Disease”.
Dr. Lisanti’s interests have spanned a
broad range of disease research, including heart disease and
diabetes, muscular dystrophy, cancer, and aging. He is widely
regarded as the world’s leading expert in the competitive field of
research on caveolins, a family of membrane-proteins which play an
important role in various aspects of cellular metabolism such as
cholesterol transport, and whose role in cell signaling and
transformation is linked with cancer, particular breast cancer.
AJP is published by and is the
official journal of the American Society for Investigative Pathology
(ASIP). ASIP’s President, Mark L. Tykocinski, MD summarized the
ASIP’s selection process by saying, “Dr. Lisanti’s scientific
curiosity and personal dynamism energize those around him, and we
are excited by what his vision and creativity can bring to the
AJP and to disease pathogenesis research as a whole.”
“We congratulate Michael Lisanti on his
well deserved appointment as Editor-in-Chief," adds Kimmel Cancer
Center director Richard Pestell, MD, PhD, Chair of the Department of
Cancer Biology at Jefferson Medical College. "His widely recognized
expertise in a number of fields makes him uniquely
qualified for the position.”
# # #
For more information on Dr. Lisanti,
please contact Steve Benowitz, Science Writer, Thomas Jefferson
University, 211 S. 9th St., Suite 310, Philadelphia PA
19107. Phone: 215-955-5291; Fax: 215-955-5008; Email:
Steven.Benowitz@jefferson.edu. |
